753924-79-7 Usage
Molecular Structure
1H-Indazole-6-carboxylic acid, 5-(4-fluorophenoxy)-1-(2-methylpropyl)is a complex organic compound that consists of a 1H-indazole ring with a carboxylic acid group at the 6 position, a 4-fluorophenoxy moiety, and a 2-methylpropyl substituent.
Functional Groups
The compound contains several functional groups, including a carboxylic acid group, a phenoxy group, and a fluorine atom.
Potential Applications
1H-Indazole-6-carboxylic acid, 5-(4-fluorophenoxy)-1-(2-methylpropyl)- has potential applications in medicinal chemistry, particularly in the development of pharmaceutical drugs. Its unique structure and functional groups make it a promising candidate for further research and development in the field of drug discovery.
Physical Properties
The physical properties of 1H-Indazole-6-carboxylic acid, 5-(4-fluorophenoxy)-1-(2-methylpropyl)are not provided in the material, so more research would be needed to determine its melting point, boiling point, solubility, etc.
Stability
The stability of 1H-Indazole-6-carboxylic acid, 5-(4-fluorophenoxy)-1-(2-methylpropyl)is not provided in the material, so more research would be needed to determine its stability under different conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 753924-79-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,5,3,9,2 and 4 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 753924-79:
(8*7)+(7*5)+(6*3)+(5*9)+(4*2)+(3*4)+(2*7)+(1*9)=197
197 % 10 = 7
So 753924-79-7 is a valid CAS Registry Number.
753924-79-7Relevant academic research and scientific papers
P38 inhibitors and methods of use thereof
-
Page/Page column 31; sheet 35, (2008/06/13)
This invention relates to inhibitors of p38, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders mediated by p38.
